Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Purdue to Accelerate Drug Discovery, Development

Published: Monday, September 16, 2013
Last Updated: Monday, September 16, 2013
Bookmark and Share
Purdue Center for Drug Discovery adds to Purdue's strengths and the capacity to translate basic research into life-changing treatments.

Purdue President Mitch Daniels has highlighted how the center will create an innovative research and teaching environment to stimulate discovery and the translation of basic research into new ways to diagnose and treat disease.

"Here, as in other areas, we will seek to reinforce existing excellence," Daniels said. "Purdue has the proven talent, knowledge and drive to create new treatments and tools that improve health worldwide. Purdue researchers are already hard at work finding the connection between the molecular basis of disease and compounds to change the course of disease. Through Purdue's Center for Drug Discovery, we will accelerate the rate of drug discovery to move revelations from the lab to commercialization and then to the million of patients who need hope and relief."

The Purdue Center for Drug Discovery supports more than 100 faculty in six colleges and its research will focus on four disease categories: cancer; diabetes, obesity and cardiovascular; immune and infectious disease; and neurological disorders and trauma.

Joining Daniels at the forum were Philip Low, the Ralph C. Corley Distinguished Professor of Chemistry and inaugural director of the center, and Timothy Ratliff, professor and the Robert Wallace Miller Director of the Purdue University Center for Cancer Research. Ratliff, Low and directors of other Purdue centers with research focused on the disease targets will meet regularly to share discoveries and ensure a unified, efficient progression of the research.

"This new Purdue center will advance the level of research among our faculty and the educational experience of our research-driven and entrepreneurially focused undergraduate and graduate students," Low said. "It will encourage collaboration. It will bring people and their distinctive talents together, accelerating our rates of discovery and translation. And it sends the message to the world that Purdue University is committed to excellence in the field of drug discovery and development."

Purdue has strengths along all of the points of the drug discovery pipeline, including a premier structural biology group with a track record of discovering new targets to block disease, a chemistry department that has produced two Nobel laureates and is a leader in structure-based drug design, and top-ranked engineering and pharmacy programs, Ratliff said.

"Purdue has all the fundamentals and a history of getting things done - including more than 30 compounds at various stages of clinical development," he said. "If we build on this strength and put infrastructure in place to overcome the remaining challenges, the university can bring many more potentially life-changing or life-saving drugs to the clinic."

In addition, 14 core units are in place to provide shared resources for analysis, screening, synthesis and testing of potential therapeutic compounds, he said.

"We don't want any potential new treatment to fail because there isn't a resource to move it forward," Ratliff said. "Perhaps the professor who made the discovery doesn't have the expertise for the next step in the process. We want to make it easy for one professor to pass the torch to another and to draw on the reserves of our talented research staff to finish the marathon of drug discovery in record time."

The new center will help increase funding from federal agencies and industry, Low said. In a time of reduced overall federal support, investment in drug discovery remains strong.

Purdue also will be in a unique position to capitalize on a trend by major pharmaceutical companies to outsource research and development to universities and biotechnology firms, he said. The industry spent $9.4 billion in outsourcing its R&D in 2011, Kalorama Information reports.

"Purdue is among an elite handful of universities that are very productive in this area, and we are well-positioned to partner with the pharmaceutical industry and become a world leader in drug discovery," Low said.

Estimates also show that it costs approximately $1.4 billion and takes 10 years to bring a new prescription drug to the market, and pharmaceutical companies want to be confident in a drug candidate before pursuing it. That means compounds already through early testing and validation are much more competitive, Low said.

"Taking a discovery further along the drug development path, which is what this center is all about, is much more lucrative for the researcher and the university," he said. "The greatest return on research investment is right after establishing a 'proof of principle,' and taking a discovery through to this point means the difference between thousands and millions of dollars for the university. These revenues represent money that can be put back into discovery research and, thereby, further enhance our potential to change the world."

Other goals of the Purdue Center for Drug Discovery, which will be a part of Discovery Park and located in a state-of-the-art facility opening next spring in the Life and Health Sciences Park on the south end of campus, include:

* The center advances Purdue's primary mission to move discoveries from the laboratories to benefit citizens. This will be accomplished as Purdue researchers translate discoveries into the clinic, and then into commercial use, and through training courses in the development of startup companies, all of which will contribute to the state's economy.
* Advancing its role as a research leader in this area, Purdue becomes even more competitive in gaining larger research grants from state and federal agencies such as the National Institutes of Health, National Science Foundation, the U.S. Department of Defense, and major foundations and philanthropic organizations.
* Cutting-edge facilities are a magnet for attracting leading faculty and top-tier students. This also accelerates efforts to develop a curriculum and a learning culture that focuses on all aspects of the drug discovery pipeline - from discovery and development to the patenting of technology and processes that can be commercialized for greater and immediate impact.

"Students will get to experience all parts of the drug discovery process and see what it takes to get all the way through," Ratliff said. "Our students also will have the opportunity to be trained for careers in very popular and in-demand areas."

More details on the initiatives will be provided by Daniels throughout the fall semester. The initiatives were selected and developed over several months of work that involved deans, faculty and others at the university. Purdue's trustees also have reviewed and given support for the program.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Friday, April 22, 2016
Environmental Cleanup Tech Rids Oil from Water
A new technology that is easy to manufacture and uses commercially available materials makes it possible to continuously remove oils and other pollutants from water, representing a potential tool for environmental cleanup.
Tuesday, April 05, 2016
Zika Virus Structure Revealed
Team at Purdue becomes the first to determine the structure of the Zika virus, which reveals insights critical to the development of effective antiviral treatments and vaccines.
Monday, April 04, 2016
Identifying Foodborne Pathogens
A Purdue University innovation that creates a "fingerprint-like pattern" to identify foodborne pathogens without using reagents has been licensed by Hettich Lab Technology.
Wednesday, March 02, 2016
'Lipidomics' Could Bring Fast Cancer Diagnosis
Researchers have developed a new analytical tool for medical applications and biological research that might be used to diagnose cancer more rapidly than conventional methods.
Wednesday, February 24, 2016
Remote-Controlled Drug Delivery
A team of researchers has created a new implantable drug-delivery system using nanowires that can be wirelessly controlled.
Thursday, June 25, 2015
Microsecond Raman Imaging Might Probe Cells, Organs for Disease
An advanced medical diagnostic tool for the early detection of cancer and other diseases.
Thursday, April 02, 2015
Purdue-Based Firms Grow After Receiving Emerging Innovations Fund Investments
The Fund has helped to support new business ventures across a range of research areas.
Friday, March 13, 2015
Keck Foundation to Fund Purdue Research into Spectroscopic Imaging
Ji-Xin Cheng leads a Purdue team awarded a $1 million W.M. Keck Foundation grant to develop a new type of imaging technology for cell and tissue analysis that could bring advanced medical diagnostics.
Tuesday, February 10, 2015
Pharmaceuticals, Personal Care Products Could Taint Swimming Pools
A new study suggests pharmaceuticals and chemicals from personal care products end up in swimming pools, possibly interacting with chlorine to produce disinfection byproducts with unknown properties and health effects.
Monday, January 12, 2015
Purdue Research Suggests Approach to Treat Virus Causing Respiratory Illness
Enterovirus D68 has stricken children with serious respiratory infections.
Monday, January 05, 2015
Drinking Water Odors, Chemicals Above Health Standards Caused by 'Green Building' Plumbing
Several types of plastic pipes in eco-friendly green buildings in the United States have been found to leach chemicals into drinking water that can cause odors and sometimes exist at levels that may exceed health standards.
Tuesday, October 21, 2014
New Technique Yields Drug, Biomedical Test Results in One Minute
Slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine.
Tuesday, October 14, 2014
Producing Orange Corn Rich in Provitamin A
Improvement of carotenoid levels in corn a simpler, faster process for plant breeders.
Saturday, October 11, 2014
New Chip Promising For Tumor-Targeting Research
The new system, called a tumor-microenvironment-on-chip device, will allow researchers to study the complex environment surrounding tumors and the barriers that prevent the targeted delivery of therapeutic agents.
Tuesday, September 23, 2014
Scientific News
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
How Skeletal Stem Cells Form The Blueprint Of The Face
USC researchers discover that two types of molecular signals work to control where and when stem cells turn into facial cartilage.
Intestinal Worms Boost Immune System In A Surprising Way
EPFL researchers find that intestinal worm infections cause lymph nodes to produce more immune cells as well as grow in size.
Measuring The Airborne Toxicants Urban Bicyclists Inhale
Researchers analyze breath biomarkers to measure uptake of volatile organic compounds by bicyclists.
Breast Milk Hormones Impact Bacteria In Infants’ Guts
Intestinal microbiome of children born to obese mothers significantly different from those born to mothers of healthy weight, CU Anschutz researchers find.
Newborn Screening Test Developed For Rare, Deadly Neurological Disorder
Scientists have developed a new dried blood spot screening test for Niemann-Pick type C, with goal to speed diagnosis and treatment.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
New Method Allows First Look At Embryo Implantation
Researchers at The Rockefeller University develop a method that shows the molecular and cellular processes that occur up to day 14 after fertilization.
Shining A Light On Bladder Cancer
Researchers scrutinize patterns of mutations in bladder tumor genomes, gleaning insights into the roles of DNA repair and tobacco-related DNA damage.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!